Skip to Content

The European Union’s drug regulator has started reviewing the efficacy and safety of China’s Sinovac COVID-19 vaccine

AMSTERDAM (AP) — The European Union’s drug regulator has started reviewing the efficacy and safety of China’s Sinovac COVID-19 vaccine.

Author Profile Photo

Associated Press

Skip to content